The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neuroblastoma Treatment Market Research Report 2024
Synopsis
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The global Neuroblastoma Treatment market was valued at US$ 444 million in 2023 and is anticipated to reach US$ 566.7 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market's growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.
This report aims to provide a comprehensive presentation of the global market for Neuroblastoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroblastoma Treatment.
Report Scope
The Neuroblastoma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuroblastoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroblastoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seattle Children’s
CureSearch
Texas Children’s
NANT
Sino Biopharmaceutical
Jiangsu Hengrui Medicine Co.,Ltd.
Fosun Pharmaceutical
Novartis
Juno Therapeutics
Kite Pharma
Adaptimmune
Segment by Type
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Chimeric Antigen Receptor T-Cell Immunotherapy
Oncolytic Virus Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroblastoma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The global Neuroblastoma Treatment market was valued at US$ 444 million in 2023 and is anticipated to reach US$ 566.7 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market's growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.
This report aims to provide a comprehensive presentation of the global market for Neuroblastoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroblastoma Treatment.
Report Scope
The Neuroblastoma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuroblastoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroblastoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seattle Children’s
CureSearch
Texas Children’s
NANT
Sino Biopharmaceutical
Jiangsu Hengrui Medicine Co.,Ltd.
Fosun Pharmaceutical
Novartis
Juno Therapeutics
Kite Pharma
Adaptimmune
Segment by Type
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Chimeric Antigen Receptor T-Cell Immunotherapy
Oncolytic Virus Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroblastoma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroblastoma Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Combination Chemotherapy
1.2.3 Monoclonal Antibody Therapy
1.2.4 Vaccine Therapy
1.2.5 Chimeric Antigen Receptor T-Cell Immunotherapy
1.2.6 Oncolytic Virus Therapy
1.3 Market by Application
1.3.1 Global Neuroblastoma Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroblastoma Treatment Market Perspective (2019-2030)
2.2 Neuroblastoma Treatment Growth Trends by Region
2.2.1 Global Neuroblastoma Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neuroblastoma Treatment Historic Market Size by Region (2019-2024)
2.2.3 Neuroblastoma Treatment Forecasted Market Size by Region (2025-2030)
2.3 Neuroblastoma Treatment Market Dynamics
2.3.1 Neuroblastoma Treatment Industry Trends
2.3.2 Neuroblastoma Treatment Market Drivers
2.3.3 Neuroblastoma Treatment Market Challenges
2.3.4 Neuroblastoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroblastoma Treatment Players by Revenue
3.1.1 Global Top Neuroblastoma Treatment Players by Revenue (2019-2024)
3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroblastoma Treatment Revenue
3.4 Global Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroblastoma Treatment Revenue in 2023
3.5 Neuroblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Neuroblastoma Treatment Product Solution and Service
3.7 Date of Enter into Neuroblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Neuroblastoma Treatment Historic Market Size by Type (2019-2024)
4.2 Global Neuroblastoma Treatment Forecasted Market Size by Type (2025-2030)
5 Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Neuroblastoma Treatment Historic Market Size by Application (2019-2024)
5.2 Global Neuroblastoma Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neuroblastoma Treatment Market Size (2019-2030)
6.2 North America Neuroblastoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neuroblastoma Treatment Market Size by Country (2019-2024)
6.4 North America Neuroblastoma Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroblastoma Treatment Market Size (2019-2030)
7.2 Europe Neuroblastoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neuroblastoma Treatment Market Size by Country (2019-2024)
7.4 Europe Neuroblastoma Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroblastoma Treatment Market Size (2019-2030)
8.2 Asia-Pacific Neuroblastoma Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroblastoma Treatment Market Size (2019-2030)
9.2 Latin America Neuroblastoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neuroblastoma Treatment Market Size by Country (2019-2024)
9.4 Latin America Neuroblastoma Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroblastoma Treatment Market Size (2019-2030)
10.2 Middle East & Africa Neuroblastoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Seattle Children’s
11.1.1 Seattle Children’s Company Detail
11.1.2 Seattle Children’s Business Overview
11.1.3 Seattle Children’s Neuroblastoma Treatment Introduction
11.1.4 Seattle Children’s Revenue in Neuroblastoma Treatment Business (2019-2024)
11.1.5 Seattle Children’s Recent Development
11.2 CureSearch
11.2.1 CureSearch Company Detail
11.2.2 CureSearch Business Overview
11.2.3 CureSearch Neuroblastoma Treatment Introduction
11.2.4 CureSearch Revenue in Neuroblastoma Treatment Business (2019-2024)
11.2.5 CureSearch Recent Development
11.3 Texas Children’s
11.3.1 Texas Children’s Company Detail
11.3.2 Texas Children’s Business Overview
11.3.3 Texas Children’s Neuroblastoma Treatment Introduction
11.3.4 Texas Children’s Revenue in Neuroblastoma Treatment Business (2019-2024)
11.3.5 Texas Children’s Recent Development
11.4 NANT
11.4.1 NANT Company Detail
11.4.2 NANT Business Overview
11.4.3 NANT Neuroblastoma Treatment Introduction
11.4.4 NANT Revenue in Neuroblastoma Treatment Business (2019-2024)
11.4.5 NANT Recent Development
11.5 Sino Biopharmaceutical
11.5.1 Sino Biopharmaceutical Company Detail
11.5.2 Sino Biopharmaceutical Business Overview
11.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Introduction
11.5.4 Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2019-2024)
11.5.5 Sino Biopharmaceutical Recent Development
11.6 Jiangsu Hengrui Medicine Co.,Ltd.
11.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Detail
11.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
11.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Introduction
11.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2019-2024)
11.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
11.7 Fosun Pharmaceutical
11.7.1 Fosun Pharmaceutical Company Detail
11.7.2 Fosun Pharmaceutical Business Overview
11.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Introduction
11.7.4 Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2019-2024)
11.7.5 Fosun Pharmaceutical Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Neuroblastoma Treatment Introduction
11.8.4 Novartis Revenue in Neuroblastoma Treatment Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Juno Therapeutics
11.9.1 Juno Therapeutics Company Detail
11.9.2 Juno Therapeutics Business Overview
11.9.3 Juno Therapeutics Neuroblastoma Treatment Introduction
11.9.4 Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2019-2024)
11.9.5 Juno Therapeutics Recent Development
11.10 Kite Pharma
11.10.1 Kite Pharma Company Detail
11.10.2 Kite Pharma Business Overview
11.10.3 Kite Pharma Neuroblastoma Treatment Introduction
11.10.4 Kite Pharma Revenue in Neuroblastoma Treatment Business (2019-2024)
11.10.5 Kite Pharma Recent Development
11.11 Adaptimmune
11.11.1 Adaptimmune Company Detail
11.11.2 Adaptimmune Business Overview
11.11.3 Adaptimmune Neuroblastoma Treatment Introduction
11.11.4 Adaptimmune Revenue in Neuroblastoma Treatment Business (2019-2024)
11.11.5 Adaptimmune Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
